Please login to the form below

Not currently logged in
Email:
Password:

Cavatek

This page shows the latest Cavatek news and features for those working in and with pharma, biotech and healthcare.

Merck buys cancer-killing virus firm Viralytics for $394m

Merck buys cancer-killing virus firm Viralytics for $394m

Merck buys cancer-killing virus firm Viralytics for $394m. It will acquire the Australian biotech’s lead cancer therapy Cavatek in the process. ... The pharma group - known as MSD outside the US and Canada - has agreed to buy Australian biotech

Latest news

  • Archive listing

    It will acquire the Australian biotech’s lead cancer therapy Cavatek in the process. .

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics